ASCLETIS-B (01672) spent $91.525 million Hong Kong dollars to repurchase 100,000 shares on October 17th.
Ka Li Pharmaceutical-B (01672) announced on October 17, 2025, that they will spend 91.525 million Hong Kong dollars to repurchase 1...
ASCLETIS-B (01672) announced that on October 17, 2025, it spent HKD 915,250 to repurchase 100,000 shares.
Related Articles
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.
MRAM, sponsored by Taiwan Semiconductor Manufacturing Co., Ltd. ADR(TSM.US), makes a significant breakthrough.
Through the hearing of the Hong Kong Stock Exchange, Pony.ai (PONY.US) accelerates cross-border capital globalization in the United States and Hong Kong.
Boeing Company (BA.US) has received approval from the FAA to increase the monthly production limit of 737 MAX aircraft to 42.
MRAM, sponsored by Taiwan Semiconductor Manufacturing Co., Ltd. ADR(TSM.US), makes a significant breakthrough.
RECOMMEND
